AMLODIPINE AND OLMESARTAN MEDOXOMIL

Generic: AMLODIPINE AND OLMESARTAN MEDOXOMIL

Micro Labs LimitedManufacturer
ORALRoute
AMLODIPINE BESYLATEActive Substance
2017-11-02Original Approval

AMLODIPINE AND OLMESARTAN MEDOXOMIL is FDA application ANDA207435, sponsored by MICRO LABS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
27 reports
2
HYPOTENSION
16 reports
3
DIARRHOEA
15 reports
4
ACUTE KIDNEY INJURY
14 reports
5
DIZZINESS
12 reports
6
SPRUE-LIKE ENTEROPATHY
12 reports
7
HYPERTENSION
11 reports
8
INTENTIONAL OVERDOSE
11 reports
9
FATIGUE
10 reports
10
HYPOKALAEMIA
10 reports